Literature DB >> 28571714

L-Tyrosine availability affects basal and stimulated catecholamine indices in prefrontal cortex and striatum of the rat.

Zachary D Brodnik1, Manda Double2, Rodrigo A España1, George E Jaskiw3.   

Abstract

We previously found that L-tyrosine (L-TYR) but not D-TYR administered by reverse dialysis elevated catecholamine synthesis in vivo in medial prefrontal cortex (MPFC) and striatum of the rat (Brodnik et al., 2012). We now report L-TYR effects on extracellular levels of catecholamines and their metabolites. In MPFC, reverse dialysis of L-TYR elevated in vivo levels of dihydroxyphenylacetic acid (DOPAC) (L-TYR 250-1000 μM), homovanillic acid (HVA) (L-TYR 1000 μM) and 3-methoxy-4-hydroxyphenylglycol (MHPG) (L-TYR 500-1000 μM). In striatum L-TYR 250 μM elevated DOPAC. We also examined L-TYR effects on extracellular dopamine (DA) and norepinephrine (NE) levels during two 30 min pulses (P2 and P1) of K+ (37.5 mM) separated by t = 2.0 h. L-TYR significantly elevated the ratio P2/P1 for DA (L-TYR 125 μM) and NE (L-TYR 125-250 μM) in MPFC but lowered P2/P1 for DA (L-TYR 250 μM) in striatum. Finally, we measured DA levels in brain slices using ex-vivo voltammetry. Perfusion with L-TYR (12.5-50 μM) dose-dependently elevated stimulated DA levels in striatum. In all the above studies, D-TYR had no effect. We conclude that acute increases within the physiological range of L-TYR levels can increase catecholamine metabolism and efflux in MPFC and striatum. Chronically, such repeated increases in L-TYR availability could induce adaptive changes in catecholamine transmission while amplifying the metabolic cost of catecholamine synthesis and degradation. This has implications for neuropsychiatric conditions in which neurotoxicity and/or disordered L-TYR transport have been implicated. Published by Elsevier Ltd.

Entities:  

Keywords:  Dopamine; Norepinephrine; Prefrontal cortex; Striatum; Tyrosine; Tyrosine hydroxylase

Mesh:

Substances:

Year:  2017        PMID: 28571714      PMCID: PMC5544352          DOI: 10.1016/j.neuropharm.2017.05.030

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  203 in total

1.  Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice.

Authors:  Marko Huotari; Joseph A Gogos; Maria Karayiorgou; Olli Koponen; Markus Forsberg; Atso Raasmaja; Juha Hyttinen; Pekka T Männistö
Journal:  Eur J Neurosci       Date:  2002-01       Impact factor: 3.386

2.  Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors.

Authors:  Andrea Anzalone; José E Lizardi-Ortiz; Maria Ramos; Claudia De Mei; F Woodward Hopf; Ciro Iaccarino; Briac Halbout; Jacob Jacobsen; Chisato Kinoshita; Marc Welter; Marc G Caron; Antonello Bonci; David Sulzer; Emiliana Borrelli
Journal:  J Neurosci       Date:  2012-06-27       Impact factor: 6.167

3.  Studies of the rate-limiting step in the tyrosine hydroxylase reaction: alternate substrates, solvent isotope effects, and transition-state analogues.

Authors:  P F Fitzpatrick
Journal:  Biochemistry       Date:  1991-07-02       Impact factor: 3.162

4.  Clozapine-induced dopamine release in the medial prefrontal cortex is augmented by a moderate concentration of locally administered tyrosine but attenuated by high tyrosine concentrations or by tyrosine depletion.

Authors:  George E Jaskiw; Bobbi Kirkbride; Erica Newbould; Damon Young; Valerie Durkalski; Rodolfo Bongiovanni
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

5.  Brain region-specific changes in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD).

Authors:  Elizabeth M Sajdel-Sulkowska; Ming Xu; Woody McGinnis; Noriyuki Koibuchi
Journal:  Cerebellum       Date:  2011-03       Impact factor: 3.847

6.  Repetitive action potentials in isolated nerve terminals in the presence of 4-aminopyridine: effects on cytosolic free Ca2+ and glutamate release.

Authors:  G R Tibbs; A P Barrie; F J Van Mieghem; H T McMahon; D G Nicholls
Journal:  J Neurochem       Date:  1989-12       Impact factor: 5.372

7.  Measurement of endogenous dopamine and norepinephrine release from superfused slices of rat prefrontal cortex in vitro: modulation by D2 and alpha-2 presynaptic receptors.

Authors:  T Ohmori; T Koyama; I Yamashita
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

8.  Tyrosine-induced release of dopamine is under inhibitory control of presynaptic dopamine D2 and, probably, D3 receptors in the dorsal striatum, but not in the nucleus accumbens.

Authors:  Koichi Fusa; Tadashi Saigusa; Noriaki Koshikawa; Alexander R Cools
Journal:  Eur J Pharmacol       Date:  2002-07-19       Impact factor: 4.432

9.  Tyrosine depletion lowers dopamine synthesis and desipramine-induced prefrontal cortex catecholamine levels.

Authors:  Rodolfo Bongiovanni; Erica Newbould; George E Jaskiw
Journal:  Brain Res       Date:  2007-11-04       Impact factor: 3.252

10.  The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis.

Authors:  B H Westerink; H M Hofsteede; G Damsma; J B de Vries
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-04       Impact factor: 3.000

View more
  4 in total

1.  Susceptibility to traumatic stress sensitizes the dopaminergic response to cocaine and increases motivation for cocaine.

Authors:  Zachary D Brodnik; Emily M Black; Meagan J Clark; Kristen N Kornsey; Nathaniel W Snyder; Rodrigo A España
Journal:  Neuropharmacology       Date:  2017-08-01       Impact factor: 5.250

2.  Targeted neurotransmitter metabolomics profiling of oleanolic acid in the treatment of spontaneously hypertensive rats.

Authors:  Ruixue Yu; Wenqing Yang; Dongmei Qi; Lili Gong; Chao Li; Yunlun Li; Haiqiang Jiang
Journal:  RSC Adv       Date:  2019-07-26       Impact factor: 4.036

3.  Deprenyl reduces inflammation during acute SIV infection.

Authors:  K M Emanuel; K Runner; Z D Brodnik; B M Morsey; B G Lamberty; H S Johnson; A Acharya; S N Byrareddy; R A España; H S Fox; P J Gaskill
Journal:  iScience       Date:  2022-04-06

4.  Increased dopamine availability magnifies nicotine effects on cognitive control: A pilot study.

Authors:  Stefan Ahrens; Joana Laux; Christina Müller; Christiane M Thiel
Journal:  J Psychopharmacol       Date:  2020-03-05       Impact factor: 4.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.